Patient Square Capital LP Roivant Sciences Ltd. Transaction History
Patient Square Capital LP
- $235 Billion
- Q1 2024
A detailed history of Patient Square Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Patient Square Capital LP holds 12,228,465 shares of ROIV stock, worth $135 Million. This represents 54.89% of its overall portfolio holdings.
Number of Shares
12,228,465
Previous 12,639,920
3.26%
Holding current value
$135 Million
Previous $142 Billion
9.2%
% of portfolio
54.89%
Previous 77.6%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
267Shares Held
488MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$803 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$763 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$734 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$398 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$392 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.75B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...